Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment

Abstract The past decade has witnessed ongoing progress in immune therapy to ameliorate human health. As an emerging technique, chimeric antigen receptor (CAR) T-cell therapy has the advantages of specific killing of cancer cells, a high remission rate of cancer-induced symptoms, rapid tumor eradica...

Full description

Bibliographic Details
Main Authors: Ting Yan, Lingfeng Zhu, Jin Chen
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Experimental Hematology & Oncology
Subjects:
CAR T cells
Solid tumor
TAAs
TSAs
TMAs
Online Access:https://doi.org/10.1186/s40164-023-00373-7

Internet

https://doi.org/10.1186/s40164-023-00373-7

Similar Items